tolfenamic-acid and Pain

tolfenamic-acid has been researched along with Pain* in 9 studies

Trials

5 trial(s) available for tolfenamic-acid and Pain

ArticleYear
Involvement of opioidergic and alpha2-adrenergic mechanisms in the central analgesic effects of non-steroidal anti-inflammatory drugs in sheep.
    Research in veterinary science, 2006, Volume: 80, Issue:2

    The level within the central nervous system where non-steroidal anti-inflammatory drugs (NSAIDs) produce analgesia and the mechanisms by which they mediate this effect are still uncertain. This study assessed the central analgesic effects of ketoprofen, phenylbutazone, salicylic acid and tolfenamic acid in sheep implanted with indwelling intrathecal (i.t.) catheters and submitted to mechanical noxious stimulation. The sheep received i.t. cumulative concentrations (0.375-200 microM; 100 microL) as well as a single intravenous (i.v.) dose (3, 8, 10 and 2 mg/kg, respectively) of each NSAID. The sheep were also given i.t. naloxone (5.49 mM; 100 microL) and atipamezole (4.03 mM; 100 microL) prior to i.v. ketoprofen. None of the i.t. NSAIDs increased mechanical thresholds. Intravenously, only ketoprofen and tolfenamic acid raised the pain thresholds. The hypoalgesic effect of i.v. ketoprofen was prevented by i.t. naloxone or atipamezole. Although NSAIDs had no direct effect on the spinal cord, their analgesic action appeared to be spinally mediated.

    Topics: Adrenergic alpha-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Female; Imidazoles; Injections, Intravenous; Injections, Spinal; Ketoprofen; Naloxone; Narcotic Antagonists; ortho-Aminobenzoates; Pain; Phenylbutazone; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Salicylic Acid; Sheep

2006
Comparative studies with tolfenamic acid in rheumatic disorders.
    Pharmacology & toxicology, 1994, Volume: 75 Suppl 2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Naproxen; ortho-Aminobenzoates; Osteoarthritis; Pain

1994
Tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea.
    Pharmacology & toxicology, 1994, Volume: 75 Suppl 2

    The clinical efficacy of tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea was studied in a prospective, controlled, double-blind, cross-over study comprising 73 patients aged 13-39 with an average body weight of 56 kilos. The patients were randomized to receive either tolfenamic acid (200 mg t.i.d.) or mefenamic acid (500 mg t.i.d.) for 3 days, during 3 consecutive menstrual cycles each, in a sequential design A-B or B-A. At the beginning and at the end of each treatment period, 13 dysmenorrhoeic symptoms were evaluated on a visual analogue scale (lower back pain, interference with daily activities, nausea, vomiting, diarrhoea, headache, dizziness, fatigue, sweating, chills, hot flashes, depressant states, and mood swings). The data were analyzed by using two statistical models. The first one, for the 73 patients, by making paired comparisons regardless of treatment sequence. With respect to the initial values, the results showed that both drugs were statistically significant (P < 0.05) in reducing the intensity of the evaluated symptoms. When comparing both treatments, tolfenamic acid showed a significant difference as to interference with daily activities (P < 0.025) and hot flashes (P < 0.005). In the result analysis with the second model, the groups were divided according to the first assigned treatment and paired comparisons were made. It was observed that the group receiving tolfenamic acid in the last sequence reached a higher level of response and statistical significance was demonstrated in 8 of 13 evaluated symptoms.(ABSTRACT TRUNCATED AT 250 WORDS)

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Drug Tolerance; Dysmenorrhea; Female; Humans; Mefenamic Acid; ortho-Aminobenzoates; Pain; Pain Measurement; Prospective Studies

1994
Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo.
    Acta neurologica Scandinavica, 1986, Volume: 73, Issue:4

    In 31 patients with at least 3 migraine attacks per month the prophylactic effect of tolfenamic acid 300 mg/day, propranolol 120 mg/day, and placebo was compared in a randomized double-blind cross-over study. The patients were treated for 12 weeks with each drug, but only the last 11 weeks were used for evaluation. Both tolfenamic acid and propranolol significantly reduced the number of attacks, the total duration of attacks and additional drugs taken when compared with placebo. Tolfenamic acid, but not propranolol, significantly reduced the median intensity of pain and the number of attacks confining the patients to their beds when compared with placebo. Only mild adverse reactions occurred with no significant difference between the drugs. It was concluded that the prophylactic effect of tolfenamic acid 300 mg/day in migraine was at least as good as propranolol 120 mg/day.

    Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; ortho-Aminobenzoates; Pain; Propranolol; Random Allocation; Time Factors; Work Capacity Evaluation

1986
Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices.
    Lancet (London, England), 1978, Aug-19, Volume: 2, Issue:8086

    The efficacy of an anti-prostaglandin, tolfenamic acid (T.A.), in the prevention of side-effects after insertion of a copper-T200 intrauterine contraceptive device (I.U.D.) was evaluated in a double-blind trial in 160 women. T.A. relieved pain and reduced bleeding after insertion and during three subsequent menstruations without serious side-effects. A scoring system for the assessment of I.U.D. side-effects showed that the acceptability of I.U.D. was significantly better in women treated with T.A. than in those given placebo.

    Topics: Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Intrauterine Devices, Copper; Menstruation Disturbances; ortho-Aminobenzoates; Pain; Placebos; Prostaglandin Antagonists; Uterine Hemorrhage

1978

Other Studies

4 other study(ies) available for tolfenamic-acid and Pain

ArticleYear
Pain alleviation during castration of piglets: a comparative study of different farm options.
    Journal of animal science, 2016, Volume: 94, Issue:12

    Pain alleviation associated with castration of piglets is an important welfare issue. The present study compares the effect of different approaches and products suitable for farmer use, with the aim to alleviate pain due to castration in piglets. A randomized within-litter design, with 28 replicate litters, compared 7 treatments: handling () restraint of the piglet and manipulation of the scrotum, castration without pain relief (), 2 treatments (, ) with different concentrations of tetracaine (2 and 6%) applied topically 10 min before and immediately post-surgery, and 3 treatments with i.m. injection of different nonsteroidal anti-inflammatory drugs () 10 min prior to surgery (-meloxicam, -ketoprofen, -tolfenamic acid). Efficacy of pain relief was assessed during a 300 min period after castration by serum cortisol, behavior (walking, lying, suckling, in the nest, isolated and pain related: tremors, rubbing the rear, hunching, wagging of the tail), facial expression and scrotal skin pressure sensitivity. C pigs had greater serum cortisol concentration than all other groups at 60 min post-surgery ( < 0.001), while H pigs had lower concentrations than pigs given topical anesthesia ( < 0.001) though not injected analgesia. No treatment differences were significant at 180 min, but at 300 min cortisol concentration was greater in T2 and T6 piglets than those given NSAIDs ( = 0.03). These treatment differences were mirrored by the pressure sensitivity of the scrotum; in comparison with C piglets, those given NSAIDs showed a reduced sensitivity ( 0.003) but those given local anesthesia did not ( = 0.15). C pigs showed increased frequency of pain-related behavior in the first 30 min in comparison with all other treatments, more time isolated than H or NSAID treatments, and more time standing inactive than H or K treatments. No behavioral differences were apparent after 60 min. No differences in facial expressions were observed among treatments. In conclusion, on-farm methods for pain relief can provide some, though not complete, pain alleviation in the hours after castration. The use of topical anesthesia gave only minor benefit in comparison to NSAID agents injected prior to castration. Since the main differences in indicators of pain between positive and negative controls were observed within the first h after castration, it is important to select drugs that act quickly after administration to facilitate practical processing schedules on farm.

    Topics: Anesthesia, Local; Animal Husbandry; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Hydrocortisone; Ketoprofen; Male; Meloxicam; Orchiectomy; ortho-Aminobenzoates; Pain; Pain Management; Swine; Thiazines; Thiazoles

2016
Effects of meloxicam or tolfenamic acid administration on the pain and stress responses of Merino lambs to mulesing.
    Australian veterinary journal, 2008, Volume: 86, Issue:8

    To determine the effectiveness of two long-acting non-steroidal anti-inflammatory drugs (NSAIDs) at reducing the pain and stress responses to mulesing in lambs.. Merino lambs (n = 60) were allocated at 5 weeks of age to six treatment groups: (1) sham mules; (2) mules; (3) tolfenamic acid-sham mules; (4) tolfenamic acid administered 45 min before mulesing; (5) tolfenamic acid at the time of mulesing; (6) meloxicam at the time of mulesing. Plasma cortisol was measured at -0.75, -0.25, 0, 0.5, 1, 3, 6, 12, 24, 48 and 72 h relative to mulesing. Beta-endorphin concentrations in plasma were determined at 0, 0.5, 1, 6, 12, 24, and 48 h. Haematology was performed on blood samples taken at -0.75, 0, 24, 48 and 72 h. Plasma haptoglobin was measured at 0, 12, 24, 48 and 72 h. Rate of wound healing was determined 72 h post mulesing, and animal behaviour, including posture, was measured for 6 h after mulesing.. The mulesed lambs exhibited large increases in plasma concentrations of cortisol, beta-endorphin and haptoglobin. All mulesed animals lost weight significantly in the week after mulesing, regardless of analgesic administration, but the difference in weight between mulesed and unmulesed lambs was less at the final measurement, 2 weeks after mulesing. Mulesed lambs spent significantly less time lying ventrally than control lambs. All lambs that were mulesed, including those administered NSAIDs, spent more time standing with a hunched posture and less time walking normally than control lambs.. The NSAID treatments applied 45 min before or at the time of mulesing at the dose levels used in this study were not effective in reducing the acute response of lambs to mulesing.

    Topics: Analgesics; Animal Welfare; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; beta-Endorphin; Female; Haptoglobins; Hydrocortisone; Male; Meloxicam; ortho-Aminobenzoates; Pain; Posture; Random Allocation; Sheep; Sheep Diseases; Thiazines; Thiazoles; Time Factors; Treatment Outcome; Wound Healing

2008
Assessment of the duration of the pain response associated with lameness in dairy cows, and the influence of treatment.
    New Zealand veterinary journal, 2008, Volume: 56, Issue:5

    To assess the welfare impact of lameness on dairy cattle in New Zealand by measuring the duration of allodynia (decreased nociceptive threshold) and increased locomotion score, and to evaluate the influence of treatment on that duration.. After lame cows were treated using corrective paring by a veterinarian, they were allocated to one of six treatment groups. If the veterinarian determined that additional elevation of the lesion was not required the cow was randomly allocated to receive one of four treatments, viz 2 mg/kg tolfenamic acid, a plastic shoe to elevate the lesion, both treatments, or no further treatment. Cows that required additional elevation were treated using a plastic shoe and then randomly allocated to two separate treatment groups, either 2 mg/kg tolfenamic acid or no further treatment. Assessments of locomotion score (based on posture and gait) and mechanical nociceptive threshold (using a pneumatically actuated blunt pin) were made prior to treatment, and 3, 8, 28 and 100 days later.. Data were collected from 149 lame cows from nine dairy farms. There were significant improvements in mean locomotion score and nociceptive threshold in all treatment groups. At all time-points after treatment, locomotion score and nociceptive threshold were significantly improved when compared with the previous time-point. Thus, in these cows, the deleterious effects of lameness persisted for longer than 28 days, despite treatment, as the mean locomotion scores and nociceptive threshold on Day 100 were better than those on Day 28. No significant long-term benefit of using tolfenamic acid at the time of treatment was observed on either locomotion score or nociceptive threshold, nor was there any benefit in using a plastic shoe in cases where it had been determined that such treatment was not necessary.. This study demonstrated that the welfare impact of lameness on dairy cattle in New Zealand is of long duration even when treated effectively. In contrast to previous studies, no significant long-term benefit of using non-steroidal anti-inflammatory drugs (NSAID) at the time of treatment was observed, probably because unlike those previous studies the nociceptive threshold improved in the cattle which did not receive an NSAID, perhaps because treated cattle were kept on pasture rather than housed.. The long duration of increased allodynia after treatment demonstrates that prevention of lameness rather than therapeutic treatment is the key to reducing its impact on the welfare of dairy cows.

    Topics: Analgesics; Animal Welfare; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Combined Modality Therapy; Female; Lameness, Animal; Locomotion; ortho-Aminobenzoates; Pain; Pain Management; Random Allocation; Severity of Illness Index; Shoes; Time Factors; Treatment Outcome

2008
Pharmacology of tolfenamic acid.
    Pharmacology & toxicology, 1994, Volume: 75 Suppl 2

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Fever; Guinea Pigs; Humans; Inflammation; Male; Mice; ortho-Aminobenzoates; Pain; Prostaglandin Antagonists; Rabbits; Rats; Stomach Ulcer

1994